Core platform
Product pipeline
Microbial Library & Synthetic
Biology Platform
CMC Platform
IIT&IND platform
Drug Discovery Platform
√ Library of 1,000+ Species & 20,000+ Bacterial
Strains
√ National Samples from 32 Provinces & Diverse Populations
√ Gene Editing for Functional & Mechanistic Validation
√ Engineered Bacterial Strains for Targeted Applications
√ FDA & CDE-certified CMC process
√ GMP pilot-scale facility
√ Multi-stage fermenters for scalable
LBP production
√ Large-scale production of any bacterial species
√ End-to-end microbial drug development
ecosystem
√ World's first gut-brain-axis therapy for depression receives FDA clearance for clinical trials
√ Multiple pipelines advancing through IIT stage
√ Diverse portfolio of clinical collaborations.
√ Proprietary Platforms( IMMUNOFIND & NEUROFIND)
√ 200+ immune cell/response molecule detection systems
√ 50+ mouse evaluation models
√ 300+ Validated Functional Strains
|
|
Address: Building 5, Phase 5, Intelligent Technology Park,
Economic and Technological Development Zone, Hefei, Anhui, China.
Tel: 0551-63813386
Email: hr@ibiome.com.cn